Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Montuschi (Rome, Italy). Nuclear magnetic resonance and mass spectrometry analysis of exhaled breath condensate. Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma Source: Eur Respir J 2012; 39: 500-502 Year: 2012 Methodological aspects of nuclear magnetic resonance spectroscopy of exhaled breath condensate Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy Source: Eur Respir J 2008; 32: 1175-1183 Year: 2008 Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects Source: Eur Respir J 2012; 39: 498-500 Year: 2012 Processing optimization of exhaled breath condensate previous to the analysis by mass spectrometry Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests Year: 2012 Detection of radicals by electron spin resonance (ESR) spectroscopy in exhaled breath condensate (EBC) Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004 Metabonomic approach for noninvasive diagnosis of inflammatory lung diseases through nuclear magnetic resonance analysis of exhaled breath condensate Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Metabonomic analysis of EBC in adults by nuclear magnetic resonance spectroscopy Source: Annual Congress 2008 - New frontiers in noninvasive assessment of the lungs Year: 2008 NMR spectroscopy of exhaled breath condensate in the diagnosis of asthma: Validation and reproducibility Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Mass-selective determination of free 3-nitrotyrosine in breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 484s Year: 2002 Human skin keratins are the major proteins in exhaled breath condensate Source: Eur Respir J 2008; 31: 380-384 Year: 2008 Methodological issues of sample collection and analysis of exhaled breath Source: Eur Respir Monogr 2010; 49: 96-114 Year: 2010 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009